http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010092415-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5ec8cb31c4eab1c04d399f3a8ef5edf8 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0065 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-06 |
| filingDate | 2009-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ba360413fe4a96d9791a03e1f0ce2d1 |
| publicationDate | 2010-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2010092415-A1 |
| titleOfInvention | Combination of hesperidin and antacids in the treatment of gastro-esophageal reflux disease (gerd) |
| abstract | The present invention relates to a composition and method for the simultaneous alleviation of the symptoms form both acute and chronic in gastro-esophageal reflux disease (GERD) and related conditions. The composition of the present invention comprises hesperidin and at least an alkaline calcium, sodium, potassium, and aluminium salt, wherein the metal salts treat the acute phase of the aforementioned disorder and hesperidin is used to treat the chronic phase. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2785424-A1 |
| priorityDate | 2009-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 66.